Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 5 Safety Stopping Rules

From: Design of the exhale airway stents for emphysema (EASE) trial: an endoscopic procedure for reducing hyperinflation

Adverse Event

Stopping Rule

Major hemoptysis

> 3 of first 100 subjects then

 

> 3% subjects or

 

> 2 subjects/study site

Respiratory failure

> 15 of first 100 subjects then

 

> 15% subjects or

 

> 2 subjects/study site

Pneumothorax

> 4 of first 20 subjects then

 

> 20% subjects or

 

> 2 subjects/study site

Death

≥2 of first 66 subjects within 30 days post procedure or >3% thereafter